vTv Therapeutics names biotechnology industry veteran Steven Tuch as CFO


Month after appointing a new CEO, High Point biopharmaceutical company vTv Therapeutics named Steven Tuch as CFO. Tuch joins the company as it looks to get back on track following several leadership changes.

Previous Operating in darkness: Ukrainian doctors learn tricks of the trade at Vanderbilt
Next UPMC to raise its starting wage to $18 an hour